{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:08:05Z","timestamp":1790744885496,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":1913,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","fertstert.org","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.fertnstert.2016.12.024","type":"journal-article","created":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T09:30:17Z","timestamp":1485509417000},"page":"537-548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy"],"prefix":"10.1016","volume":"107","author":[{"given":"Mohamed A.","family":"Bedaiwy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Allaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukinah","family":"Alfaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2016.12.024_bib1","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(04)17403-5","article-title":"Endometriosis","volume":"364","author":"Giudice","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib2","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/j.fertnstert.2009.11.027","article-title":"High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners [letter]","volume":"93","author":"Ilangavan","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000093019","article-title":"The prevalence of endometriosis in women with chronic pelvic pain","volume":"62","author":"Guo","year":"2006","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib4","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.fertnstert.2007.08.051","article-title":"Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial","volume":"90","author":"Harada","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib5","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/0002-9378(92)91706-G","article-title":"Hormone treatment of endometriosis: the estrogen threshold hypothesis","volume":"166","author":"Barbieri","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib6","first-page":"45","article-title":"Is there a solution for recurrent endometriosis?","volume":"72","author":"Evers","year":"1991","journal-title":"Br J Clin Pract Suppl"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jpag.2011.06.012","article-title":"High rate of endometriosis recurrence in young women","volume":"24","author":"Tandoi","year":"2011","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib8","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.fertnstert.2014.02.012","article-title":"Treatment of pelvic pain associated with endometriosis: a committee opinion","volume":"101","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-2003-41327","article-title":"Medical therapy of endometriosis","volume":"21","author":"Olive","year":"2003","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib10","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/humupd\/dms026","article-title":"Anti-angiogenic treatment strategies for the therapy of endometriosis","volume":"18","author":"Laschke","year":"2012","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.steroids.2003.08.003","article-title":"All progestins are not created equal","volume":"68","author":"Stanczyk","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib12","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2165\/00003495-199856050-00007","article-title":"Dienogest","volume":"56","author":"Foster","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib13","first-page":"134","article-title":"Progestogens in menopausal hormone therapy","volume":"14","author":"Bi\u0144kowska","year":"2015","journal-title":"Prz Menopauzalny"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijgo.2009.08.020","article-title":"A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis","volume":"108","author":"K\u00f6hler","year":"2010","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib15","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.fertnstert.2007.12.080","article-title":"Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis\u2014a randomized, double-blind, multicenter, controlled trial","volume":"91","author":"Harada","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00011-015-0909-7","article-title":"Does dienogest influence the inflammatory response of endometriotic cells?","volume":"65","author":"Grandi","year":"2016","journal-title":"Inflamm Res"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib17","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/molehr\/gaw054","article-title":"TNF\u03b1-induced IKK\u03b2 complex activation influences epithelial, but not stromal cell survival in endometriosis","volume":"22","author":"Kocbek","year":"2016","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejogrb.2010.04.002","article-title":"Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study","volume":"151","author":"Strowitzki","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00404-011-1941-7","article-title":"Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment","volume":"285","author":"Petraglia","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2147\/IJWH.S77202","article-title":"Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program","volume":"7","author":"Strowitzki","year":"2015","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib21","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3109\/09513590.2015.1006617","article-title":"Dienogest: a possible conservative approach in bladder endometriosis: results of a pilot study","volume":"31","author":"Angioni","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib22","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0015-0282(01)03270-8","article-title":"Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study","volume":"77","author":"Cosson","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib23","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.fertnstert.2015.11.016","article-title":"Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study","volume":"105","author":"Vercellini","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib24","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/humrep\/dep469","article-title":"Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial","volume":"25","author":"Strowitzki","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib25","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/aogs.12633","article-title":"Gonadotrophin-releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis: a multi-center randomized trial","volume":"94","author":"Granese","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib26","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/jog.12030","article-title":"Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel-releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients","volume":"39","author":"Morelli","year":"2013","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib27","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1177\/1933719114556488","article-title":"Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate\/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study","volume":"22","author":"Grandi","year":"2015","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib28","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s40618-015-0383-7","article-title":"Quality of life and sexual function of women affected by endometriosis-associated pelvic pain when treated with dienogest","volume":"38","author":"Caruso","year":"2015","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib29","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s40618-016-0460-6","article-title":"Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest\/30 \u03bcg ethinyl estradiol continuous or 21\/7 regimen oral contraceptive","volume":"39","author":"Caruso","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib30","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1447-0756.2009.01076.x","article-title":"Long-term use of dienogest for the treatment of endometriosis","volume":"35","author":"Momoeda","year":"2009","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00404-015-3681-6","article-title":"Dienogest in the treatment of endometriosis: systematic review","volume":"292","author":"de Paula Andres","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/jog.12527","article-title":"Dienogest for the treatment of deep endometriosis: case report and literature review","volume":"41","author":"Agarwal","year":"2015","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib33","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3109\/09513590.2010.533800","article-title":"Dienogest, a new conservative strategy for extragenital endometriosis: a pilot study","volume":"27","author":"Harada","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib34","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.contraception.2010.04.004","article-title":"The use of newer progestins for contraception","volume":"82","author":"Sitruk-Ware","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib35","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/09513590902770149","article-title":"Long-term oral contraceptive treatment, metabolic syndrome and measures of cardiovascular risk in pre-menopausal women: National Health and Nutrition Examination Survey 1999\u20132004","volume":"25","author":"Hurwitz","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib36","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1517\/14656566.2013.767334","article-title":"An update on the pharmacological management of endometriosis","volume":"14","author":"Streuli","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1056\/NEJM199101103240205","article-title":"Gonadotropin-releasing hormone and its analogues","volume":"324","author":"Conn","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib38","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.fertnstert.2008.09.077","article-title":"Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists","volume":"91","author":"Bedaiwy","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib39","first-page":"581","article-title":"Cell growth effects of leuprolide on cultured endometrioma cells","volume":"52","author":"Levine","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-014-0306-y","article-title":"GnRH agonists induce endometrial epithelial cell apoptosis via GRP78 down-regulation","volume":"12","author":"Weng","year":"2014","journal-title":"J Transl Med"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib41","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/en.2009-0541","article-title":"The kisspeptin\/neurokinin B\/dynorphin (KNDy) cell population of the arcuate nucleus: sex differences and effects of prenatal testosterone in sheep","volume":"151","author":"Cheng","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib42","doi-asserted-by":"crossref","first-page":"11859","DOI":"10.1523\/JNEUROSCI.1569-09.2009","article-title":"Regulation of gonadotropin-releasing hormone secretion by kisspeptin\/dynorphin\/neurokinin B neurons in the arcuate nucleus of the mouse","volume":"29","author":"Navarro","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib43","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1210\/jc.2016-1911","article-title":"Investigating the KNDy hypothesis in humans by coadministration of kisspeptin, neurokinin B, and naltrexone in men","volume":"101","author":"Narayanaswamy","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 3","key":"10.1016\/j.fertnstert.2016.12.024_bib44","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1016\/j.fertnstert.2016.07.788","article-title":"Differential expression of Kisspeptin in patients with and without endometriosis","volume":"106","author":"Abdelkareem","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib45","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0015-0282(99)00636-6","article-title":"Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy (\u201cdraw-back\u201d therapy)","volume":"73","author":"Tahara","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib46","first-page":"584","volume":"48","author":"Song","year":"2013","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib47","first-page":"51","article-title":"Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis. Pelvic Pain Study Group","volume":"93","author":"Ling","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib48","first-page":"523","article-title":"Depot leuprorelin acetate versus danazol in the treatment of infertile women with symptomatic endometriosis","volume":"23","author":"Rotondi","year":"2002","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib49","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejogrb.2006.10.034","article-title":"A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III\u2013IV endometriosis","volume":"136","author":"Loverro","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib50","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00404-010-1599-6","article-title":"A comparison of the effect of short-term aromatase inhibitor (letrozole) and GnRH agonist (triptorelin) versus case control on pregnancy rate and symptom and sign recurrence after laparoscopic treatment of endometriosis","volume":"284","author":"Alborzi","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tjog.2015.04.004","article-title":"Low-dose add-back therapy during postoperative GnRH agonist treatment","volume":"55","author":"Tsai","year":"2016","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib52","article-title":"The effects of GnRHa plus add-back therapy on quality of life for adolescents with endometriosis: a randomized controlled trial","author":"Gallagher","year":"2016","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib53","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/09513599709152533","article-title":"A double-blind randomized study of the treatment of endometriosis with nafarelin or nafarelin plus norethisterone","volume":"11","author":"Bergqvist","year":"1997","journal-title":"Gynecol Endocrinol"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2016.12.024_bib54","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000052848","article-title":"Steroidal \u2018add-back\u2019 therapy in patients treated with GnRH agonists","volume":"45","author":"Freundl","year":"1998","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib55","first-page":"709","article-title":"Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up","volume":"99","author":"Surrey","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib56","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0015-0282(00)00690-7","article-title":"Gonadotropin-releasing hormone agonist plus \u201cadd-back\u201d hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial","volume":"74","author":"Franke","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib57","first-page":"97","article-title":"Delayed oral estradiol combined with leuprolide increases endometriosis-related pain","volume":"4","author":"Hurst","year":"2000","journal-title":"JSLS"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib58","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/humrep\/deh250","article-title":"One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial","volume":"19","author":"Fernandez","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib59","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/AOG.0000000000000964","article-title":"Hormonal add-back therapy for females treated with gonadotropin-releasing hormone agonist for endometriosis: a randomized controlled trial","volume":"126","author":"DiVasta","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib60","first-page":"504","volume":"44","author":"Wang","year":"2009","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib61","first-page":"CD008475","article-title":"Gonadotrophin-releasing hormone analogues for pain associated with endometriosis","author":"Prentice","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib62","first-page":"CD008475","article-title":"Gonadotrophin-releasing hormone analogues for pain associated with endometriosis","author":"Brown","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib63","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jmig.2013.01.019","article-title":"Combined surgical and hormone therapy for endometriosis is the most effective treatment: prospective, randomized, controlled trial","volume":"20","author":"Alkatout","year":"2013","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib64","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jtcvs.2004.04.039","article-title":"Catamenial pneumothorax revisited: clinical approach and systematic review of the literature","volume":"128","author":"Korom","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib65","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1477-7827-9-88","article-title":"Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial","volume":"9","author":"Ferrero","year":"2011","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib66","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0015-0282(98)00500-7","article-title":"Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached? Add-Back Consensus Working Group","volume":"71","author":"Surrey","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib67","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0015-0282(16)57530-X","article-title":"Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain","volume":"63","author":"Hornstein","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib68","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.fertnstert.2005.12.030","article-title":"Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain","volume":"86","author":"Bedaiwy","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib69","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0029-7844(97)00620-0","article-title":"Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group","volume":"91","author":"Hornstein","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib70","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1447-0756.1999.tb01166.x","article-title":"Low-dose GnRH agonist therapy for the management of endometriosis","volume":"25","author":"Uemura","year":"1999","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib71","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000258683","article-title":"Efficacy of gonadotropin-releasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis","volume":"69","author":"Kang","year":"2009","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib72","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1083-3188(96)70021-9","article-title":"Endometriosis in an adolescent population: the Emory experience","volume":"9","author":"Reese","year":"1996","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"Suppl 3","key":"10.1016\/j.fertnstert.2016.12.024_bib73","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S1083-3188(03)00066-4","article-title":"Adolescent endometriosis: diagnosis and\u00a0treatment approaches","volume":"16","author":"Laufer","year":"2003","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib74","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/humrep\/der156","article-title":"Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis","volume":"26","author":"Chapron","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib75","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/AOG.0b013e3181e8b073","article-title":"Practice bulletin no. 114: management of endometriosis","volume":"116","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"Suppl 2","key":"10.1016\/j.fertnstert.2016.12.024_bib76","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1701-2163(16)34589-3","article-title":"Endometriosis: diagnosis and management","volume":"32","author":"Leyland","year":"2010","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib77","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/humrep\/det457","article-title":"ESHRE guideline: management of women with endometriosis","volume":"29","author":"Dunselman","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib78","first-page":"CD000155","article-title":"Ovulation suppression for endometriosis for women with subfertility","author":"Hughes","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib79","first-page":"CD004635","article-title":"Long-term pituitary down-regulation before in\u00a0vitro fertilization (IVF) for women with endometriosis","author":"Sallam","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2016.12.024_bib80","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1210\/jc.2012-1558","article-title":"The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis","volume":"97","author":"Raffi","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216630960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216630960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T02:49:30Z","timestamp":1666493370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028216630960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0015028216630960"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.12.024","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727254542.793557765","asserted-by":"object"}]},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92017 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}